Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Cadernos de Saúde Pública |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2016001405009 |
Resumo: | Abstract: The Brazilian pharmaceutical industry is heavily dependent on external sources of inputs, capital, and technology. However, the emergence of technological opportunities and the development of biotechnology and the decline of the patent boom and resulting advances by generic drugs have opened windows of opportunities for the local industry. The article examines the Brazilian industry's innovative behavior vis-à-vis these opportunities, showing that although the industry as a whole invests little in innovation, a few large Brazilian companies have expanded their market share and stepped up their investments in research and development, supported by public policies for innovation. |
id |
FIOCRUZ-5_688a86b1cb18f9e6f5bdfe8f8a4fe471 |
---|---|
oai_identifier_str |
oai:scielo:S0102-311X2016001405009 |
network_acronym_str |
FIOCRUZ-5 |
network_name_str |
Cadernos de Saúde Pública |
repository_id_str |
|
spelling |
Windows of opportunities and technological innovation in the Brazilian pharmaceutical industryDrug IndustryGeneric DrugsSustainable DevelopmentInnovationAbstract: The Brazilian pharmaceutical industry is heavily dependent on external sources of inputs, capital, and technology. However, the emergence of technological opportunities and the development of biotechnology and the decline of the patent boom and resulting advances by generic drugs have opened windows of opportunities for the local industry. The article examines the Brazilian industry's innovative behavior vis-à-vis these opportunities, showing that although the industry as a whole invests little in innovation, a few large Brazilian companies have expanded their market share and stepped up their investments in research and development, supported by public policies for innovation.Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz2016-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2016001405009Cadernos de Saúde Pública v.32 suppl.2 2016reponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZ10.1590/0102-311X00103315info:eu-repo/semantics/openAccessTigre,Paulo BastosNascimento,Caio Victor Machado França doCosta,Laís Silveiraeng2016-11-01T00:00:00Zoai:scielo:S0102-311X2016001405009Revistahttp://cadernos.ensp.fiocruz.br/csp/https://old.scielo.br/oai/scielo-oai.phpcadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2016-11-01T00:00Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.none.fl_str_mv |
Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry |
title |
Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry |
spellingShingle |
Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry Tigre,Paulo Bastos Drug Industry Generic Drugs Sustainable Development Innovation |
title_short |
Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry |
title_full |
Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry |
title_fullStr |
Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry |
title_full_unstemmed |
Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry |
title_sort |
Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry |
author |
Tigre,Paulo Bastos |
author_facet |
Tigre,Paulo Bastos Nascimento,Caio Victor Machado França do Costa,Laís Silveira |
author_role |
author |
author2 |
Nascimento,Caio Victor Machado França do Costa,Laís Silveira |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Tigre,Paulo Bastos Nascimento,Caio Victor Machado França do Costa,Laís Silveira |
dc.subject.por.fl_str_mv |
Drug Industry Generic Drugs Sustainable Development Innovation |
topic |
Drug Industry Generic Drugs Sustainable Development Innovation |
description |
Abstract: The Brazilian pharmaceutical industry is heavily dependent on external sources of inputs, capital, and technology. However, the emergence of technological opportunities and the development of biotechnology and the decline of the patent boom and resulting advances by generic drugs have opened windows of opportunities for the local industry. The article examines the Brazilian industry's innovative behavior vis-à-vis these opportunities, showing that although the industry as a whole invests little in innovation, a few large Brazilian companies have expanded their market share and stepped up their investments in research and development, supported by public policies for innovation. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2016001405009 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2016001405009 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/0102-311X00103315 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz |
publisher.none.fl_str_mv |
Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz |
dc.source.none.fl_str_mv |
Cadernos de Saúde Pública v.32 suppl.2 2016 reponame:Cadernos de Saúde Pública instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Cadernos de Saúde Pública |
collection |
Cadernos de Saúde Pública |
repository.name.fl_str_mv |
Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br |
_version_ |
1754115737171001344 |